As the crosslinking of PD-L1 positive target cells with T cells mediated by the Y111 bispecific antibody was expected to cause the effector T-cell–dependent lysis of the target cells (14), we checked whether Y111 redirected the fresh T cells to kill PD-L1 positive tumor cells. Here, CD274 is linked to neoplasm.